Skip to main content
SpringerLink
Log in

Irregular drug intake and serum chlorpropamide concentrations

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In patients with maturity onset diabetes serum chlorpropamide concentrations (s-CPA) and fasting blood glucose (FBG) were measured before and after self recording of drug intake in order to evaluate the role of compliance with the therapeutic regimen in variation in s-CPA and clinical outcome. Nine out of 57 patients (16%) had to be excluded because they did not comply with the clinical routines and the test procedure. of the remaining 48 patients, only two recorded small deviations from the prescribed dosage, and nine (19%) noted variations in medication time of more than ±2 h. By contrast, irregular drug intake was indicated in 29 of the 48 patients (60%) based on statistical evaluation of changes in s-CPA. Clinical control (FBG) was influenced significantly in only half of these 29 patients. Improved adherence to the dietary regimen was observed in 12 of the 48 patients (25%). Patient medication behaviour seems to be an important determinant of variation in s-CPA, and is as important as adherence to the dietary regimen in clinical control of “drug requiring” patients with maturity onset diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alván G (1978) Individual differences in the disposition of drugs metabolised in the body. Clin Pharmacokinet 3: 155–175

    Google Scholar 

  2. Sjöqvist F, Borgå O, Orme ML'E (1976) Fundamentals of clinical pharmacology. In: Avery GS (Ed) Drug treatment. Principles and practice of clinical pharmacology and therapeutics. Adis Press, Churchill Livingstone, Sydney London, pp 1–42

    Google Scholar 

  3. Sackett DL (1976) The magnitude of compliance and noncompliance: In: Sackett DL, Haynes RB (eds) Compliance with therapeutic regimens. Baltimore: John Hopkins University Press, Baltimore, pp 9–25

    Google Scholar 

  4. Bechtel P, Richard A, Sandoz M, Grandmottet P, Narboni G, Schwager JC (1976) Usefulness of determination of plasma concentrations of glicazide in monitoring the treatment of diabetics. In: Siest G, Young N, Young DS (eds) Drug interference and drug measurement in clinical chemistry. Karger, Basel, pp 153–158

    Google Scholar 

  5. Melander A, Sartor G, Wåhlin E, Scherstén B, Bitzén PO (1978) Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. Br. Med. J. 1: 142–144

    Google Scholar 

  6. Bergman U, Christenson I, Jansson B, Wiholm B-E, Östman J (1980) Wide variation in serum chlorpropamide concentration in outpatients. Eur J Clin Pharmacol 18: 165–169

    Google Scholar 

  7. Bergman U (1978) Utilization of antidiabetic drugs in the island of Gotland, Swedem — agreement between wholesales figures and prescription data. Eur J Clin Pharmacol 14: 213–220

    Google Scholar 

  8. Bergman U (1978) Drug utilization — geographical differences and clinical implications — antidiabetic drugs. In: Duchéne-Marullaz P (ed) Advances in pharmacology and therapeutics. Vol. 6. Pergamon Press, Oxford New York, pp 123–132

    Google Scholar 

  9. Prescott LF, Redman DR (1972) Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma. J Pharm Pharmacol 24: 713–716

    Google Scholar 

  10. Watkins JD, Williams TF, Martin DA, Hogan MD, Anderson E (1967) A study of diabetic patients at home. Am J Public Health 57: 452–459

    Google Scholar 

  11. Davis MS (1966) Variations in patients' compliance with Doctors' Orders: Analysis of Congruence Between Survey Responses and Results of Empirical Investigations. J Med Educ 41: 1037–1048

    Google Scholar 

  12. Charney E, Bynum R, Eldredge D, Frank D, MacWhinney, JB, McNabb N, Scheiner A, Sumpter E, Iker H (1967) How well do patients take oral penicillin? J Pediat 40: 188–195

    Google Scholar 

  13. Caron HS, Roth HP (1968) Patients' Cooperation with a Medical Regimen. J Am Med Assoc 203: 922–926

    Google Scholar 

  14. Roth HP, Caron HS, Hsi BP (1971) Estimating a patient's cooperation with his regimen. Am J Med Sci 262: 269–273

    Google Scholar 

  15. Roth HP, Caron HS (1978) Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen. Clin Pharmacol Ther 23: 361–370

    Google Scholar 

  16. Norell SE (1980) Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med in press

  17. Feinstein AR, Wood HF, Epstein JA, Taranta A, Simson R, Tursky E (1959) A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. N Engl J Med 260: 697–702

    Google Scholar 

  18. Bergman AB, Werner RJ (1963) Failure of children to receive penicillin by mouth. N Engl J Med 268: 1334–1338

    Google Scholar 

  19. Park LC, Lipman RS (1964) A comparison of patient dosage deviation reports with pill counts. Psychopharmacologia 6: 299–302

    Google Scholar 

  20. Rickels K, Briscoe E (1970) Assessment of dosage deviation in outpatient drug research. J Clin Pharmacol 10: 153–160

    Google Scholar 

  21. Hecht AB (1974) Improving medication compliance by teaching outpatients. Nurs Forum 13: 113–129

    Google Scholar 

  22. Chaves AD (1960) Results of the PAS urine test (Phenistix) study done in May and June, 1959. Am Rev Respir Dis 81: 111–112

    Google Scholar 

  23. Preston DF, Miller FL (1964) The tuberculosis outpatient's defection from therapy. Am J Med Sci 247: 21–25

    Google Scholar 

  24. Wilcox DRC, Gillan R, Hane EH (1965) Do psychiatric outpatients take their drugs? Br Med J 2: 790–792

    Google Scholar 

  25. Gordis L, Markowitz M, Lilienfeld AM (1969) The Inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care 7: 49–54

    Google Scholar 

  26. Eshelman FN, Fitzloff J (1976) Effect of packaging on patient compliance with an antihypertensive medication. Curr Ther Res 20: 215–219

    Google Scholar 

  27. Sackett DL, Haynes RB, Gibson ES, Hackett BC, Taylor DW, Roberts RS, Johnson AL (1975) Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1: 1205–1207

    Google Scholar 

  28. Taylor JA (1972) Pharmacokinetics and biotransformation of chlorpropamide in man. Clin Pharmacol Ther 13: 710–718

    Google Scholar 

  29. Gundert-Remy U, Remy C, Weber E (1976) Serum digoxin levels in patients of a general practice in Germany. Eur J Clin Pharmacol 10: 97–100

    Google Scholar 

  30. Johnston GD, Kelly JG, McDevitt DG (1978) Do patients take digoxin? Br Heart J 40: 1–7

    Google Scholar 

  31. Johnston GD, McDevitt DG (1978) Digoxin compliance in patients from general practice. Br J Clin Pharmacol 6: 339–343

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Internal Medicine, Karolinska Institutet, Huddinge University Hospital, Huddinge, Sweden

    B. -E. Wiholm

Authors
  1. B. -E. Wiholm
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wiholm, B.E. Irregular drug intake and serum chlorpropamide concentrations. Eur J Clin Pharmacol 18, 159–163 (1980). https://doi.org/10.1007/BF00561584

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561584

Key words

Search

Navigation